U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Hemoptysis

MedGen UID:
5502
Concept ID:
C0019079
Sign or Symptom
Synonym: Hemoptyses
SNOMED CT: Hemoptysis (66857006); Coughing up blood (66857006); Blood streaked sputum (6686005)
 
HPO: HP:0002105

Definition

Coughing up (expectoration) of blood or blood-streaked sputum from the larynx, trachea, bronchi, or lungs. [from HPO]

Term Hierarchy

Conditions with this feature

Cystic fibrosis
MedGen UID:
41393
Concept ID:
C0010674
Disease or Syndrome
Cystic fibrosis (CF) is a multisystem disease affecting epithelia of the respiratory tract, exocrine pancreas, intestine, hepatobiliary system, and exocrine sweat glands. Morbidities include recurrent sinusitis and bronchitis, progressive obstructive pulmonary disease with bronchiectasis, exocrine pancreatic deficiency and malnutrition, pancreatitis, gastrointestinal manifestations (meconium ileus, rectal prolapse, distal intestinal obstructive syndrome), liver disease, diabetes, male infertility due to hypoplasia or aplasia of the vas deferens, and reduced fertility or infertility in some women. Pulmonary disease is the major cause of morbidity and mortality in CF.
Idiopathic pulmonary hemosiderosis
MedGen UID:
9403
Concept ID:
C0020807
Disease or Syndrome
Idiopathic pulmonary hemosiderosis is a respiratory disease due to repeated episodes of diffuse alveolar hemorrhage without any underlying apparent cause, most often in children. Anemia, cough, and pulmonary infiltrates on chest radiographs are found in majority of the patients.
Alpha-1-antitrypsin deficiency
MedGen UID:
67461
Concept ID:
C0221757
Disease or Syndrome
Alpha-1 antitrypsin deficiency (AATD) can present with hepatic dysfunction in individuals from infancy to adulthood and with chronic obstructive lung disease (emphysema and/or bronchiectasis), characteristically in individuals older than age 30 years. Individuals with AATD are also at increased risk for panniculitis (migratory, inflammatory, tender skin nodules which may ulcerate on legs and lower abdomen) and C-ANCA-positive vasculitis (granulomatosis with polyangiitis). Phenotypic expression varies within and between families. In adults, smoking is the major factor in accelerating the development of COPD; nonsmokers may have a normal life span, but can also develop lung and/or liver disease. Although reported, emphysema in children with AATD is extremely rare. AATD-associated liver disease, which is present in only a small portion of affected children, manifests as neonatal cholestasis. The incidence of liver disease increases with age. Liver disease in adults (manifesting as cirrhosis and fibrosis) may occur in the absence of a history of neonatal or childhood liver disease. The risk for hepatocellular carcinoma (HCC) is increased in individuals with AATD.
Ehlers-Danlos syndrome, classic type, 1
MedGen UID:
78660
Concept ID:
C0268335
Disease or Syndrome
Classic Ehlers-Danlos syndrome (cEDS) is a connective tissue disorder characterized by skin hyperextensibility, atrophic scarring, and generalized joint hypermobility (GJH). The skin is soft and doughy to the touch, and hyperextensible, extending easily and snapping back after release (unlike lax, redundant skin, as in cutis laxa). The skin is fragile, as manifested by splitting of the dermis following relatively minor trauma, especially over pressure points (knees, elbows) and areas prone to trauma (shins, forehead, chin). Wound healing is poor, and stretching of scars after apparently successful primary wound healing is characteristic. Complications of joint hypermobility, such as dislocations of the shoulder, patella, digits, hip, radius, and clavicle, usually resolve spontaneously or are easily managed by the affected individual. Other features include hypotonia with delayed motor development, fatigue and muscle cramps, and easy bruising. Mitral valve prolapse can occur infrequently, but tends to be of little clinical consequence. Aortic root dilatation has been reported, appears to be more common in young individuals, and rarely progresses.
Ehlers-Danlos syndrome, classic type, 2
MedGen UID:
120628
Concept ID:
C0268336
Disease or Syndrome
Classic Ehlers-Danlos syndrome (cEDS) is a connective tissue disorder characterized by skin hyperextensibility, atrophic scarring, and generalized joint hypermobility (GJH). The skin is soft and doughy to the touch, and hyperextensible, extending easily and snapping back after release (unlike lax, redundant skin, as in cutis laxa). The skin is fragile, as manifested by splitting of the dermis following relatively minor trauma, especially over pressure points (knees, elbows) and areas prone to trauma (shins, forehead, chin). Wound healing is poor, and stretching of scars after apparently successful primary wound healing is characteristic. Complications of joint hypermobility, such as dislocations of the shoulder, patella, digits, hip, radius, and clavicle, usually resolve spontaneously or are easily managed by the affected individual. Other features include hypotonia with delayed motor development, fatigue and muscle cramps, and easy bruising. Mitral valve prolapse can occur infrequently, but tends to be of little clinical consequence. Aortic root dilatation has been reported, appears to be more common in young individuals, and rarely progresses.
Ehlers-Danlos syndrome, type 4
MedGen UID:
82790
Concept ID:
C0268338
Disease or Syndrome
Vascular Ehlers-Danlos syndrome (vEDS) is characterized by arterial, intestinal, and/or uterine fragility; thin, translucent skin; easy bruising; characteristic facial appearance (thin vermilion of the lips, micrognathia, narrow nose, prominent eyes); and an aged appearance to the extremities, particularly the hands. Vascular dissection or rupture, gastrointestinal perforation, or organ rupture are the presenting signs in most adults with vEDS. Arterial rupture may be preceded by aneurysm, arteriovenous fistulae, or dissection but also may occur spontaneously. The majority (60%) of individuals with vEDS who are diagnosed before age 18 years are identified because of a positive family history. Neonates may present with clubfoot, hip dislocation, limb deficiency, and/or amniotic bands. Approximately half of children tested for vEDS in the absence of a positive family history present with a major complication at an average age of 11 years. Four minor diagnostic features – distal joint hypermobility, easy bruising, thin skin, and clubfeet – are most often present in those children ascertained without a major complication.
Anti-glomerular basement membrane disease
MedGen UID:
140788
Concept ID:
C0403529
Disease or Syndrome
Goodpasture syndrome, also known as anti-GBM disease, is a rare autoimmune disease consisting of alveolar hemorrhage and glomerulonephritis secondary to circulating antiglomerular basement membrane (anti-GBM) antibodies. Anti-GBM antibodies are directed against an antigen intrinsic to the alpha-3 chain of type IV collagen (COL4A3; 120070) that is expressed in the GBMs of the glomerular capillary loops and the basal membrane of the pulmonary alveoli. Goodpasture syndrome is suspected in patients with hemoptysis and hematuria and is confirmed by the presence of anti-GBM antibodies in renal biopsy specimens and serum. Patients with human leukocyte antigen HLA-DR15 and HLA-DR4 are susceptible to the development of Goodpasture syndrome. Reported cases of familial Goodpasture syndrome are extremely rare (summary by Angioi et al., 2017).
Autoimmune pulmonary alveolar proteinosis
MedGen UID:
410079
Concept ID:
C1970472
Disease or Syndrome
Pulmonary alveolar proteinosis is a pathologic entity characterized by intraalveolar surfactant accumulation. There are 3 clinically distinct forms: hereditary (usually congenital), secondary, and acquired. The acquired form of pulmonary alveolar proteinosis is the most common form, accounting for approximately 90% of cases. The mean age at diagnosis is 39 years and it is associated with smoking in 72% of cases. The estimated incidence and prevalence are 0.36 and 3.70 cases per million, respectively (Trapnell et al., 2003; Seymour and Presneill, 2002). Secondary pulmonary alveolar proteinosis develops in association with conditions involving functional impairment or reduced numbers of alveolar macrophages. Such conditions include some hematologic cancers, pharmacologic immunosuppression, inhalation of inorganic dust or toxic fumes, and certain infections. Congenital pulmonary alveolar proteinosis is a rare, severe, often fatal disorder of newborns associated with pulmonary surfactant metabolism dysfunction caused by mutations in genes involved in surfactant metabolism (see, e.g., SMDP1, 265120) (Trapnell et al., 2003). See 300770 for information on congenital PAP due to CSF2RA (306250) deficiency.
Sarcoidosis, susceptibility to, 2
MedGen UID:
436694
Concept ID:
C2676468
Finding
Any sarcoidosis in which the cause of the disease is a mutation in the BTNL2 gene.
Sarcoidosis, susceptibility to, 1
MedGen UID:
394568
Concept ID:
C2697310
Finding
Any sarcoidosis in which the cause of the disease is a mutation in the HLA-DRB1 gene.
Primary ciliary dyskinesia 20
MedGen UID:
761920
Concept ID:
C3540844
Disease or Syndrome
CILD20 is an autosomal recessive ciliopathy characterized by infantile onset of chronic sinopulmonary infections resulting from immotile cilia and defective clearance. Patients may also have situs inversus or cardiac anomalies. Electron microscopy of respiratory epithelial cells shows absence of the outer dynein arms. Unlike other forms of CILD, patients with CILD20 do not appear to be infertile. For a phenotypic description and a discussion of genetic heterogeneity of primary ciliary dyskinesia, see 244400.
Telangiectasia, hereditary hemorrhagic, type 1
MedGen UID:
1643786
Concept ID:
C4551861
Disease or Syndrome
Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.
Portal hypertension, noncirrhotic, 2
MedGen UID:
1794158
Concept ID:
C5561948
Disease or Syndrome
Noncirrhotic portal hypertension-2 (NCPH2) is an autosomal recessive disorder characterized by signs of liver dysfunction that become apparent in the first decades of life. Affected individuals have jaundice, hyperbilirubinemia, pancytopenia, including neutropenia, lymphopenia, and thrombocytopenia, hepatosplenomegaly, and esophageal varices. Some patients may have recurrent infections or features suggestive of an immunodeficiency. Liver biopsy is notable for the absence of cirrhosis and the presence of nodular regeneration. Liver sinusoidal endothelial cells (LSECs) have abnormal expression of CD34 (142230) (summary by Drzewiecki et al., 2021). For a discussion of genetic heterogeneity of NCPH, see 617068.
Immunodeficiency 113 with autoimmunity and autoinflammation
MedGen UID:
1851770
Concept ID:
C5882711
Disease or Syndrome
Immunodeficiency-113 with autoimmunity and autoinflammation (IMD113) is an autosomal recessive complex immunologic disorder with onset of symptoms in infancy. Affected individuals have recurrent infections and usually show features of autoimmunity and autoinflammation, such as hemolytic anemia, thrombocytopenia, hepatosplenomegaly, leukocytosis, neutrophilia, and elevated acute phase reactants. More variable systemic features may include celiac disease or enteropathy, ileus, nephropathy, eczema, and dermatomyositis. Additional features include facial dysmorphism, scoliosis, and poor wound healing. One patient with neurodevelopmental abnormalities has been reported. The disorder results from dysregulation of the actin cytoskeleton that affects certain cell lineages (Nunes-Santos et al., 2023).

Professional guidelines

PubMed

O'Gurek D, Choi HYJ
Am Fam Physician 2022 Feb 1;105(2):144-151. PMID: 35166503
Ittrich H, Bockhorn M, Klose H, Simon M
Dtsch Arztebl Int 2017 Jun 5;114(21):371-381. doi: 10.3238/arztebl.2017.0371. PMID: 28625277Free PMC Article
Earwood JS, Thompson TD
Am Fam Physician 2015 Feb 15;91(4):243-9. PMID: 25955625

Recent clinical studies

Etiology

Saha BK
Respir Med 2021 Jan;176:106234. Epub 2020 Nov 17 doi: 10.1016/j.rmed.2020.106234. PMID: 33246295
Wand O, Guber E, Guber A, Epstein Shochet G, Israeli-Shani L, Shitrit D
Chest 2018 Dec;154(6):1379-1384. Epub 2018 Oct 12 doi: 10.1016/j.chest.2018.09.026. PMID: 30321510
Ittrich H, Bockhorn M, Klose H, Simon M
Dtsch Arztebl Int 2017 Jun 5;114(21):371-381. doi: 10.3238/arztebl.2017.0371. PMID: 28625277Free PMC Article
Cordovilla R, Bollo de Miguel E, Nuñez Ares A, Cosano Povedano FJ, Herráez Ortega I, Jiménez Merchán R
Arch Bronconeumol 2016 Jul;52(7):368-77. Epub 2016 Feb 9 doi: 10.1016/j.arbres.2015.12.002. PMID: 26873518
Earwood JS, Thompson TD
Am Fam Physician 2015 Feb 15;91(4):243-9. PMID: 25955625

Diagnosis

O'Gurek D, Choi HYJ
Am Fam Physician 2022 Feb 1;105(2):144-151. PMID: 35166503
Davidson K, Shojaee S
Chest 2020 Jan;157(1):77-88. Epub 2019 Jul 30 doi: 10.1016/j.chest.2019.07.012. PMID: 31374211
Ittrich H, Bockhorn M, Klose H, Simon M
Dtsch Arztebl Int 2017 Jun 5;114(21):371-381. doi: 10.3238/arztebl.2017.0371. PMID: 28625277Free PMC Article
Cordovilla R, Bollo de Miguel E, Nuñez Ares A, Cosano Povedano FJ, Herráez Ortega I, Jiménez Merchán R
Arch Bronconeumol 2016 Jul;52(7):368-77. Epub 2016 Feb 9 doi: 10.1016/j.arbres.2015.12.002. PMID: 26873518
Earwood JS, Thompson TD
Am Fam Physician 2015 Feb 15;91(4):243-9. PMID: 25955625

Therapy

Gopinath B, Mishra PR, Aggarwal P, Nayaka R, Naik SR, Kappagantu V, Shrimal P, Ramaswami A, Bhoi S, Jamshed N, Sinha TP, Ekka M, Kumar A
Chest 2023 May;163(5):1176-1184. Epub 2022 Nov 19 doi: 10.1016/j.chest.2022.11.021. PMID: 36410494
Prey B, Francis A, Williams J, Krishnadasan B
Surg Clin North Am 2022 Jun;102(3):465-481. doi: 10.1016/j.suc.2021.11.002. PMID: 35671767
O'Gurek D, Choi HYJ
Am Fam Physician 2022 Feb 1;105(2):144-151. PMID: 35166503
Wand O, Guber E, Guber A, Epstein Shochet G, Israeli-Shani L, Shitrit D
Chest 2018 Dec;154(6):1379-1384. Epub 2018 Oct 12 doi: 10.1016/j.chest.2018.09.026. PMID: 30321510
Cordovilla R, Bollo de Miguel E, Nuñez Ares A, Cosano Povedano FJ, Herráez Ortega I, Jiménez Merchán R
Arch Bronconeumol 2016 Jul;52(7):368-77. Epub 2016 Feb 9 doi: 10.1016/j.arbres.2015.12.002. PMID: 26873518

Prognosis

Deutsch-Feldman M, Pratt RH, Price SF, Tsang CA, Self JL
MMWR Morb Mortal Wkly Rep 2021 Mar 26;70(12):409-414. doi: 10.15585/mmwr.mm7012a1. PMID: 33764959Free PMC Article
Pan CX, Palathra BC, Leo-To WF
Med Clin North Am 2020 May;104(3):455-470. Epub 2020 Feb 20 doi: 10.1016/j.mcna.2019.12.004. PMID: 32312409
Alexandre AT, Vale A, Gomes T
Sarcoidosis Vasc Diffuse Lung Dis 2019;36(1):47-52. Epub 2019 May 1 doi: 10.36141/svdld.v36i1.7160. PMID: 32476936Free PMC Article
Paraschiv M
J Med Life 2014 Sep 15;7(3):343-8. Epub 2014 Sep 25 PMID: 25408752Free PMC Article
Rosen DJ, Stavropoulos C, Travis WD, Ashton RC, Bhora FY, Connery CP
Ann Thorac Surg 2008 Jul;86(1):310-2. doi: 10.1016/j.athoracsur.2007.10.016. PMID: 18573451

Clinical prediction guides

Gopinath B, Mishra PR, Aggarwal P, Nayaka R, Naik SR, Kappagantu V, Shrimal P, Ramaswami A, Bhoi S, Jamshed N, Sinha TP, Ekka M, Kumar A
Chest 2023 May;163(5):1176-1184. Epub 2022 Nov 19 doi: 10.1016/j.chest.2022.11.021. PMID: 36410494
Saha BK
Respir Med 2021 Jan;176:106234. Epub 2020 Nov 17 doi: 10.1016/j.rmed.2020.106234. PMID: 33246295
Alexandre AT, Vale A, Gomes T
Sarcoidosis Vasc Diffuse Lung Dis 2019;36(1):47-52. Epub 2019 May 1 doi: 10.36141/svdld.v36i1.7160. PMID: 32476936Free PMC Article
Wand O, Guber E, Guber A, Epstein Shochet G, Israeli-Shani L, Shitrit D
Chest 2018 Dec;154(6):1379-1384. Epub 2018 Oct 12 doi: 10.1016/j.chest.2018.09.026. PMID: 30321510
Le Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Bounameaux H, Perrier A
Ann Intern Med 2006 Feb 7;144(3):165-71. doi: 10.7326/0003-4819-144-3-200602070-00004. PMID: 16461960

Recent systematic reviews

Figueroa-Parra G, Meade-Aguilar JA, Langenfeld HE, González-Treviño M, Hocaoglu M, Hanson AC, Prokop LJ, Murad MH, Cartin-Ceba R, Specks U, Majithia V, Crowson CS, Duarte-García A
Clin Immunol 2023 Nov;256:109775. Epub 2023 Sep 16 doi: 10.1016/j.clim.2023.109775. PMID: 37722463
Yan M, Louie AV, Kotecha R, Ashfaq Ahmed M, Zhang Z, Guckenberger M, Kim MS, Lo SS, Scorsetti M, Tree AC, Sahgal A, Slotman BJ
Lung Cancer 2023 Aug;182:107281. Epub 2023 Jun 21 doi: 10.1016/j.lungcan.2023.107281. PMID: 37393758
Andres MP, Arcoverde FVL, Souza CCC, Fernandes LFC, Abrão MS, Kho RM
J Minim Invasive Gynecol 2020 Feb;27(2):373-389. Epub 2019 Oct 13 doi: 10.1016/j.jmig.2019.10.004. PMID: 31618674
Panda A, Bhalla AS, Goyal A
Diagn Interv Radiol 2017 Jul-Aug;23(4):307-317. doi: 10.5152/dir.2017.16454. PMID: 28703105Free PMC Article
Bannister M
Int J Pediatr Otorhinolaryngol 2017 Jan;92:99-102. Epub 2016 Oct 24 doi: 10.1016/j.ijporl.2016.10.021. PMID: 28012543

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...